Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Freegold Intersects 1.53 g/t Au over 191.3m in infill drilling at Golden Summit (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Sonoma Pharmaceuticals Inc
SNOA
Healthcare
Drug Manufacturers - Specialty & Generic
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin...
fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel. The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irr...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:SNOA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(249)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Apr 23, 2025 9:27am
Still staying with this stock.
It is signalling a continuing uptrend for it today,so good luck to all of us shareholders out there who are staying with this one,and
(249)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 11, 2025 9:10am
Buy buddy buy because it's taking off this morning.
This stock is signalling a big upswing for today
DiagnosTear Announces Clinical Study with AlyaTec
posted Dec 04, 2025 9:00am by
Diagnostear Technologies Inc
-
|
TeaRx™ Red Eye is being developed as the first rapid, multi-biomarker diagnostic test designed to differentiate between Adenoviral conjunctivitis, Herpetic keratitis, and Allergic conjunctivitis at the point of care. These three conditions drive hundreds of millions of clinic visits every year, yet misdiagnosis remains widespread due to the absence of fast, accurate testing. TeaRx™ aims to change that with a simple test that delivers clinical answers in minutes. ...read more
(249)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 10, 2025 7:56am
Buy buddy buy.
This stock is signalling strength to the upside this morning,so good luck to all
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 6:55am
Sonoma Pharmaceuticals (NASDAQ:SNOA) Poised for Growth with
https://beyondspx.com/2024/08/01/sonoma-pharmaceuticals-nasdaqsnoa-poised-for-growth-with-innovative-hypochlorous-acid-products/
(59)
•••
Nibinator
X
Post by
Nibinator
on Dec 05, 2023 1:41pm
Last call at .22
Final rush to .25
(59)
•••
Nibinator
X
Post by
Nibinator
on Dec 05, 2023 6:51am
Try a buy around .26 this morning
High on hopes
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 14, 2023 4:32pm
New Press Release - Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results
Cash burn of $717,000 for the quarter ended December 31, 2022, 68% less than prior quarter cash burn of $2,235,000Revenues for three and nine months ended December 31, 2022 essentially flat with strong performance in international salesEuropean revenues increased 51% for the quarter and 29% for...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 31, 2023 7:30am
New Press Release - Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea
BOULDER, CO / ACCESSWIRE / January 31, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including dermatology, eye, oral and...
read article.
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 26, 2023 2:01pm
SNOA .... Vols are light today but it's still trying ; )
The $2.10 target is still a pivot for today A volume spike would be a good catalyst GL
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 4:03pm
SNOA .... 99 million shares traded today....up 49 cents ; )
What a deal..... The Pros really earned their keep today ; )
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 3:54pm
SNOA ...... No Bounce for Bonzo ????
Take a close look at todays 5 min charts on SNOA & FWBI See how similar they are !!!!! Use it to your advantage Cheers ....going skiing !
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 3:42pm
SNOA .... 20 mins til closing
I did say support at $1.60 Let's see what happens
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 2:18pm
SNOA .... Ok ... a trend change on low volume
Next target is $2.10 I'm in !
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 2:08pm
SNOA ....pay no attention to "The Man Behind the Curtain"
No volume.... $1.90 Pfffftttt
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 25, 2023 1:46pm
SNOA ....Strike 3....yer out!!!!!!!!!!!!!!!!!!!
Now we're playing "Spear-catching" Not for everyone because this is dangerous Keeo your powder dry Cheers
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A Company Focused on Developing Functional Healthier “Better For You” Foods
A tungsten producer and developer in Portugal, South Korea & Spain on track to become a top supplier
Sorrento Resources Provides Update on Exploration on Rodgers Cove Project, Newfoundland
Building Momentum in One of the World's Most Prospective Copper Regions
DiagnosTear Announces Clinical Study to Advance Analytical Validation & FDA Submission Pathway of TeaRx(TM)